Black Diamond Therapeutics (BDTX) FCF Margin (2025)

Black Diamond Therapeutics' FCF Margin history spans 1 years, with the latest figure at 76.3% for Q1 2025.

  • For Q1 2025, FCF Margin changed N/A year-over-year to 76.3%; the TTM value through Dec 2025 reached 42.31%, changed N/A, while the annual FY2025 figure was 42.31%, N/A changed from the prior year.
  • FCF Margin reached 76.3% in Q1 2025 per BDTX's latest filing.
  • In the past five years, FCF Margin ranged from a high of 76.3% in Q1 2025 to a low of 76.3% in Q1 2025.